Prognostic factors for outcomes and complications for primary squamous cell carcinoma of the vagina treated with radiation

Gynecologic Oncology

Volumn 105, Issue 3, 2007, Pages 641-649

  Tran, Phuoc T ^a   Su, Zheng ^b   Lee, Percy ^a   Lavori, Philip ^b   Husain, Amreen ^c   Teng, Nelson ^c   Kapp, Daniel S ^a  

^a STANFORD CANCER INSTITUTE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hysterectomy; Radiation therapy; Squamous cell; Treatment hemoglobin level; Vaginal cancer

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; TUMOR VOLUME; VAGINA CARCINOMA; VAGINAL HYSTERECTOMY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; RADIOTHERAPY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VAGINAL NEOPLASMS;

EID: 34248345509     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2007.01.033     Document Type: Article

References (49)

1. Pride G.L., Schultz A.E., Chuprevich T.W., and Buchler D.A. Primary invasive squamous carcinoma of the vagina. Obstet Gynecol. 53 2 (1979 (Feb)) 218-225
2. Rubin S.C., Young J., and Mikuta J.J. Squamous carcinoma of the vagina: treatment, complications, and long-term follow-up. Gynecol Oncol. 20 3 (1985 (Mar)) 346-353
3. Eddy G.L., Marks Jr. R.D., Miller III M.C., and Underwood Jr. P.B. Primary invasive vaginal carcinoma. Am. J. Obstet. Gynecol. 165 2 (1991 (Aug)) 292-296 [discussion 6-8]
4. Kosary C.L. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina. Semin. Surg. Oncol. 10 1 (1994 (Jan-Feb)) 31-46
5. Hellman K., Silfversward C., Nilsson B., Hellstrom A.C., Frankendal B., and Pettersson F. Primary carcinoma of the vagina: factors influencing the age at diagnosis. The Radiumhemmet series 1956-96. Int. J. Gynecol. Cancer 14 3 (2004 (May-Jun)) 491-501
6. Stock R.G., Chen A.S., and Seski J. A 30-year experience in the management of primary carcinoma of the vagina: analysis of prognostic factors and treatment modalities. Gynecol. Oncol. 56 1 (1995 (Jan)) 45-52
7. Frank S.J., Jhingran A., Levenback C., and Eifel P.J. Definitive radiation therapy for squamous cell carcinoma of the vagina. Int. J. Radiat. Oncol. Biol. Phys. 62 1 (2005 (May 1)) 138-147
8. Perez C.A., Grigsby P.W., Garipagaoglu M., Mutch D.G., and Lockett M.A. Factors affecting long-term outcome of irradiation in carcinoma of the vagina. Int. J. Radiat. Oncol. Biol. Phys. 44 1 (1999 (Apr. 1)) 37-45
9. Urbanski K., Kojs Z., Reinfuss M., and Fabisiak W. Primary invasive vaginal carcinoma treated with radiotherapy: analysis of prognostic factors. Gynecol. Oncol. 60 1 (1996 (Jan)) 16-21
10. Kirkbride P., Fyles A., Rawlings G.A., Manchul L., Levin W., Murphy K.J., et al. Carcinoma of the vagina-experience at the Princess Margaret Hospital (1974-1989). Gynecol. Oncol. 56 3 (1995 (Mar)) 435-443
11. Creasman W.T., Phillips J.L., and Menck H.R. The National Cancer Data Base report on cancer of the vagina. Cancer 83 5 (1998 (Sep 1)) 1033-1040
12. Reddy S., Lee M.S., Graham J.E., Yordan E.L., Phillips R., Saxena V.S., et al. Radiation therapy in primary carcinoma of the vagina. Gynecol. Oncol. 26 1 (1987 (Jan)) 19-24
13. Spirtos N.M., Doshi B.P., Kapp D.S., and Teng N. Radiation therapy for primary squamous cell carcinoma of the vagina: Stanford University experience. Gynecol. Oncol. 35 1 (1989 (Oct)) 20-26
14. Fine B.A., Piver M.S., McAuley M., and Driscoll D. The curative potential of radiation therapy in the treatment of primary vaginal carcinoma. Am. J. Clin. Oncol. 19 1 (1996 (Feb)) 39-44
15. Benedet J.L., Bender H., Jones III H., Ngan H.Y., and Pecorelli S. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int. J. Gynaecol. Obstet. 70 2 (2000 (Aug)) 209-262
16. Nag S., and Gupta N. A simple method of obtaining equivalent doses for use in HDR brachytherapy. Int. J. Radiat. Oncol. Biol. Phys. 46 2 (2000 (Jan 15)) 507-513
17. Martinez A., Cox R.S., and Edmundson G.K. A multiple-site perineal applicator (MUPIT) for treatment of prostatic, anorectal, and gynecologic malignancies. Int. J. Radiat. Oncol. Biol. Phys. 10 2 (1984 (Feb)) 297-305
18. Hughes-Davies L., Silver B., and Kapp D.S. Parametrial interstitial brachytherapy for advanced or recurrent pelvic malignancy: the Harvard/Stanford experience. Gynecol. Oncol. 58 1 (1995 (Jul)) 24-27
19. Vaupel P., Mayer A., and Hockel M. Impact of hemoglobin levels on tumor oxygenation: the higher, the better?. Strahlenther. Onkol. 182 2 (2006 (Feb)) 63-71
20. Grogan M., Thomas G.M., Melamed I., Wong F.L., Pearcey R.G., Joseph P.K., et al. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer 86 8 (1999 (Oct 15)) 1528-1536
21. Kapp K.S., Stuecklschweiger G.F., Kapp D.S., Poschauko J., Pickel H., Lahousen M., et al. Prognostic factors in patients with carcinoma of the uterine cervix treated with external beam irradiation and IR-192 high-dose-rate brachytherapy. Int. J. Radiat. Oncol. Biol. Phys. 42 3 (1998 (Oct. 1)) 531-540
22. Fyles A.W., Milosevic M., Pintilie M., Syed A., and Hill R.P. Anemia, hypoxia and transfusion in patients with cervix cancer: a review. Radiother Oncol. 57 1 (2000 (Oct)) 13-19
23. Kapp K.S., Poschauko J., Geyer E., Berghold A., Oechs A.C., Petru E., et al. Evaluation of the effect of routine packed red blood cell transfusion in anemic cervix cancer patients treated with radical radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 54 1 (2002 (Sep 1)) 58-66
24. Leyland-Jones B., Semiglazov V., Pawlicki M., Pienkowski T., Tjulandin S., Manikhas G., et al. Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study. J. Clin. Oncol. 23 25 (2005 (Sep 1)) 5960-5972
25. Henke M., Laszig R., Rube C., Schafer U., Haase K.D., Schilcher B., et al. Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet 362 9392 (2003 (Oct 18)) 1255-1260
26. Wun T., Law L., Harvey D., Sieracki B., Scudder S.A., and Ryu J.K. Increased incidence of symptomatic venous thrombosis in patients with cervical carcinoma treated with concurrent chemotherapy, radiation, and erythropoietin. Cancer 98 7 (2003 (Oct 1)) 1514-1520
27. Anders J.C., Grigsby P.W., and Singh A.K. Cisplatin chemotherapy (without erythropoietin) and risk of life-threatening thromboembolic events in carcinoma of the uterine cervix: the tip of the iceberg? A review of the literature. Radiat. Oncol. 1 (2006) 14
28. Manetta A., Pinto J.L., Larson J.E., Stevens Jr. C.W., Pinto J.S., and Podczaski E.S. Primary invasive carcinoma of the vagina. Obstet. Gynecol. 72 1 (1988 (Jul)) 77-81
29. Mawson A.R. The place of hysterectomy in the management of benign uterine disease. HMO Pract. 10 2 (1996 (Jun)) 69-74
30. Stuart G.C., Allen H.H., and Anderson R.J. Squamous cell carcinoma of the vagina following hysterectomy. Am. J. Obstet. Gynecol. 139 3 (1981 (Feb 1)) 311-315
31. Vinokurova S., Wentzensen N., Einenkel J., Klaes R., Ziegert C., Melsheimer P., et al. Clonal history of papillomavirus-induced dysplasia in the female lower genital tract. J. Natl. Cancer Inst. 97 24 (2005 (Dec 21)) 1816-1821
32. Chyle V., Zagars G.K., Wheeler J.A., Wharton J.T., and Delclos L. Definitive radiotherapy for carcinoma of the vagina: outcome and prognostic factors. Int. J. Radiat. Oncol. Biol. Phys. 35 5 (1996 (Jul 15)) 891-905
33. Hellman K., Lundell M., Silfversward C., Nilsson B., Hellstrom A.C., and Frankendal B. Clinical and histopathologic factors related to prognosis in primary squamous cell carcinoma of the vagina. Int. J. Gynecol. Cancer 16 3 (2006 (May-Jun)) 1201-1211
34. Grigsby P.W., Russell A., Bruner D., Eifel P., Koh W.J., Spanos W., et al. Late injury of cancer therapy on the female reproductive tract. Int. J. Radiat. Oncol. Biol. Phys. 31 5 (1995 (Mar 30)) 1281-1299
35. Robinson J.W., Faris P.D., and Scott C.B. Psychoeducational group increases vaginal dilation for younger women and reduces sexual fears for women of all ages with gynecological carcinoma treated with radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 44 3 (1999 (Jun 1)) 497-506
36. Lamoreaux W.T., Grigsby P.W., Dehdashti F., Zoberi I., Powell M.A., Gibb R.K., et al. FDG-PET evaluation of vaginal carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 62 3 (2005 (Jul 1)) 733-737
37. Green J.A. Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer: a meta-analysis. Clin. Oncol. (Royal College of Radiologists (Great Britain)) 16 1 (2004 (Feb)) 82
38. Kersh C.R., Constable W.C., Spaulding C.A., Hahn S.S., Andersen W.A., and Taylor P.T. A phase I-II trial of multimodality management of bulky gynecologic malignancy. Combined chemoradiosensitization and radiotherapy. Cancer 66 1 (1990 (Jul 1)) 30-34
39. Roberts W.S., Hoffman M.S., Kavanagh J.J., Fiorica J.V., Greenberg H., Finan M.A., et al. Further experience with radiation therapy and concomitant intravenous chemotherapy in advanced carcinoma of the lower female genital tract. Gynecol. Oncol. 43 3 (1991 (Dec)) 233-236
40. Dalrymple J.L., Russell A.H., Lee S.W., Scudder S.A., Leiserowitz G.S., Kinney W.K., et al. Chemoradiation for primary invasive squamous carcinoma of the vagina. Int. J. Gynecol. Cancer 14 1 (2004 (Jan-Feb)) 110-117
41. Chan P., Yeo I., Perkins G., Fyles A., and Milosevic M. Dosimetric comparison of intensity-modulated, conformal, and four-field pelvic radiotherapy boost plans for gynecologic cancer: a retrospective planning study. Radiat. Oncol. 1 (2006) 13
42. Aktas M., de Jong D., Nuyttens J.J., van der Zee J., Wielheesen D.H., Batman E., et al. Concomitant radiotherapy and hyperthermia for primary carcinoma of the vagina: a cohort study. Eur. J. Obstet. Gynecol. Reprod. Biol. (2006 (Jun 13)) [Epub ahead of print]
43. Westermann A.M., Jones E.L., Schem B.C., van der Steen-Banasik E.M., Koper P., Mella O., et al. First results of triple-modality treatment combining radiotherapy, chemotherapy, and hyperthermia for the treatment of patients with stage IIB, III, and IVA cervical carcinoma. Cancer 104 4 (2005 (Aug 15)) 763-770
44. Dixit S., Singhal S., and Baboo H.A. Squamous cell carcinoma of the vagina: a review of 70 cases. Gynecol Oncol 48 (1993) 80-87
45. Lee W.R., Marcus Jr. R.B., Sombeck M.D., et al. Radiotherapy alone for carcinoma of the vagina: the importance of overall treatment time. Int J Radiat Oncol Biol Phys 29 (1994) 983-988
46. Kucera H., Mock U., Knocke T.H., et al. Radiotherapy alone for invasive vaginal cancer: outcome with intracavitary high dose rate brachytherapy versus conventional low dose rate brachytherapy. Acta Obstet Gynecol Scand 80 (2001) 355-360
47. Beller U., Sideri M., Maisonneuve P., et al. Carcinoma of the vagina. J Epidemiol Biostat 6 (2001) 141-152
48. Tewari K.S., Cappuccini F., Puthawala A.A., et al. Primary invasive carcinoma of the vagina: treatment with interstitial brachytherapy. Cancer 91 (2001) 758-770
49. Eddy G.L., Jenrette J.M., and Creasman W.T. Effect of radiotherapeutic technique on local control in primary vaginal carcinoma. Int J Gynecol Cancer 3 (1993) 399-404